Answers are grounded in this paper and cite their sources.
Preregistered secondary analysis of QualiSUS Cardio, Brazil's first-cycle pay-for-performance increment for adult cardiac surgery (Oct 2022–Sep 2023). Primary outcome: 30-day operative mortality in any location, from probabilistic linkage of public SIH-SUS and SIM records, never computed by the authors. Difference-in-differences with an equivalence test (±1 percentage point); secondary dose-response by financial intensity, shock 2 as a separate estimand, four prespecified effect modifiers and case-mix/coding changes. The earlier study (doi:10.17605/OSF.IO/B3ZXD) was discontinued; prior knowledge is disclosed. Protocol v1 SHA-256: 267daeac724340d427bfa286fa9ba1de675277138ca73754fe918989d856d0c0
No takes yet. Share an insight, caveat, or question.
Queiroga et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: